Cue screaming headlines about fear and loathing at the top of government, and a deeply awkward public appearance for the ...
The Calamos Global Opportunities Fund returned 6.42%, capturing a majority of the 7.74% return of the MSCI ACWI Index and ...
Q3 2025 revenue of €143.1 million for YORVIPATH® and €50.7 million for SKYTROFA® – Q3 2025 operating profit of €11.0 million – TransCon® CNP (navepegritide) under FDA Priority Review for the treatment ...
Q3 2025 review for the. See how overweight tech positions drove outperformance and explore our bullish outlook on Europe & ...
Nordic strategy delivers profitable growth - financial guidance maintainedMatas Group's strategy to Win the Nordics ...
FLSmidth & Co. A/S 12 November 2025 Copenhagen, Denmark Today, the Board of Directors of FLSmidth have approved the Q3 2025 Interim Financial Report. Highlights ...
Ramsay Santé Group reported a consolidated revenue of €1,207m for the quarter ending 30 September 2025, up 2.6% on a reported ...
Fried chicken consistently ranks as a staple on lists of all-time great comfort foods. That appreciation has manifested ...
No. 23 / 2025Zealand Pharma Announces Financial Results for the First Nine Months of 2025With petrelintide advancing at ...
Copenhagen, Denmark, 13 November 2025, (GLOBE NEWSWIRE) - BioPorto A/S ("BioPorto” or the "Company”) (CPH:BIOPOR), announces that the private placement of 40,438,426 new shares has been completed. The ...
Euro US Dollar, British Pound US Dollar, Australian Dollar US Dollar, US Dollar Polish Zloty. Read 's Market Analysis on ...
In 2025, Tokmanni Group expects its revenue to be EUR 1,700-1,790 million. Comparable EBIT is expected to be EUR 85-105 million. The Board of Directors of Tokmanni Group Corporation has decided not to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback